Literature DB >> 25438457

New biological treatments for psoriatic arthritis.

Piercarlo Sarzi-Puttini, Fabiola Atzeni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25438457

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  3 in total

1.  S100A8/A9 is not essential for the development of inflammation and joint pathology in interleukin-1 receptor antagonist knockout mice.

Authors:  Irene Di Ceglie; Peter L E M van Lent; Edwin J W Geven; Marije I Koenders; Arjen B Blom; Thomas Vogl; Johannes Roth; Martijn H J van den Bosch
Journal:  Arthritis Res Ther       Date:  2021-08-19       Impact factor: 5.156

Review 2.  Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis.

Authors:  Ennio Lubrano; Fabio Massimo Perrotta
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

3.  S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.

Authors:  Edwin J W Geven; Martijn H J van den Bosch; Irene Di Ceglie; Giuliana Ascone; Shahla Abdollahi-Roodsaz; Annet W Sloetjes; Sven Hermann; Michael Schäfers; Fons A J van de Loo; Peter M van der Kraan; Marije I Koenders; Dirk Foell; Johannes Roth; Thomas Vogl; Peter L E M van Lent
Journal:  Arthritis Res Ther       Date:  2016-10-24       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.